[Chronic myeloid leukemia: progress and prospects].
Baccarani
M
M
Cattedra di Ematologia, Università di Udine.
Russo
D
D
Fanin
R
R
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001752:Blast Crisis; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D003131:Combined Modality Therapy; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000473:pathology / Q000628:therapy; D010677:Philadelphia Chromosome; D011379:Prognosis; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D016044:Fusion Proteins, bcr-abl
Leucemia mieloide cronica: progressi e prospettive.